← FDA Drug Approvals (Drugs@FDA)

IBUPROFEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2017-06-23

Drug application

FDA Application #

ANDA209204

Application type

Abbreviated New Drug Application (Generic)

Brand name

IBUPROFEN

Generic name

IBUPROFEN

Active ingredients

IBUPROFEN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

SUN PHARMA CANADA

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2017-06-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown